Host: Ayse Tuba Kendi, MD   Guest: A. Oliver Sartor, MD  Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT). In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.

Host: Ayse Tuba Kendi, MD Guest: A. Oliver Sartor, MD Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT). In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.

Improved Outcomes in mCRPC with PSMA-Directed Diagnostics and Therapies


Host: Paul Doghramji, MD   Guest: Megan Arnot  Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.

Host: Paul Doghramji, MD Guest: Megan Arnot Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.

Investigating the Link Between Sexual Activity & Menopause Onset


Host: Mario R. Nacinovich, Jr., MSc   Guest: Kara Rood, MD  A recent study following 346 pregnant patients found that 63 percent of the women were admitted into the hospital for uncertain diagnosis or delivery—all because preeclampsia has many of the same symptoms of other diseases. The good news, however, is that there’s a new test currently underway that could make the diagnosis and treatment of preeclampsia easier in order to prevent potentially dangerous outcomes for the mother and baby, as OB/GYN Dr. Kara Rood explains.

Host: Mario R. Nacinovich, Jr., MSc Guest: Kara Rood, MD A recent study following 346 pregnant patients found that 63 percent of the women were admitted into the hospital for uncertain diagnosis or delivery—all because preeclampsia has many of the same symptoms of other diseases. The good news, however, is that there’s a new test currently underway that could make the diagnosis and treatment of preeclampsia easier in order to prevent potentially dangerous outcomes for the mother and baby, as OB/GYN Dr. Kara Rood explains.

Unmasking Preeclampsia, the Great Masquerader


Host: Brian P. McDonough, MD, FAAFP  Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people contracting HPV at some point in their lives. Host Dr. Brian McDonough is joined by Samantha Gottlieb, medical anthropologist and author of Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. They explore the history of Gardasil, a vaccine developed for HPV but marketed primarily as a cervical cancer vaccine, which became embroiled in sociopolitical debates about adolescent sexuality and pediatric vaccinations. The two discuss these precedents alongside current controversies, such as whether vaccinating both males and females will induce herd immunity, and if the benefits outweigh the risks.

Host: Brian P. McDonough, MD, FAAFP Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people contracting HPV at some point in their lives. Host Dr. Brian McDonough is joined by Samantha Gottlieb, medical anthropologist and author of Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. They explore the history of Gardasil, a vaccine developed for HPV but marketed primarily as a cervical cancer vaccine, which became embroiled in sociopolitical debates about adolescent sexuality and pediatric vaccinations. The two discuss these precedents alongside current controversies, such as whether vaccinating both males and females will induce herd immunity, and if the benefits outweigh the risks.

Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer


Host: Matt Rosenberg, MD   Guest: Aiden Harrington, ANP, CNM  Current CDC Treatment Guidelines include transgender men and women as special populations. These guidelines recommend risk assessment based on current anatomy and sexual behaviors and screening for asymptomatic STIs based on the patient's history and sexual practices. At a recent live event recorded in Chicago, moderator Dr. Matt T. Rosenberg welcomes Aiden Harrington, ANP, CNM from Howard Brown Health in Chicago, Illinois. Topics covered include health risks in the LGBTQ community, STI screening and treatment, and how to discuss sexuality with your patients. 

Host: Matt Rosenberg, MD Guest: Aiden Harrington, ANP, CNM Current CDC Treatment Guidelines include transgender men and women as special populations. These guidelines recommend risk assessment based on current anatomy and sexual behaviors and screening for asymptomatic STIs based on the patient's history and sexual practices. At a recent live event recorded in Chicago, moderator Dr. Matt T. Rosenberg welcomes Aiden Harrington, ANP, CNM from Howard Brown Health in Chicago, Illinois. Topics covered include health risks in the LGBTQ community, STI screening and treatment, and how to discuss sexuality with your patients.

STI Screening & Counseling Strategies for Transgender Patients


Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG   Guest: Heidi Faith  Doulas have become an integral part of the obstetrics field. In recent years, a new, specialized type of doula, called the bereavement doula, has emerged. But what roles and duties are performed by this care provider?  Host Dr. Renee Allen speaks with Heidi Faith, Founder, President and CEO of StillBirthDay, a highly specialized doula program. The two talk about the unique care roles a bereavement doula can play in the labor and delivery of stillborn babies.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG Guest: Heidi Faith Doulas have become an integral part of the obstetrics field. In recent years, a new, specialized type of doula, called the bereavement doula, has emerged. But what roles and duties are performed by this care provider? Host Dr. Renee Allen speaks with Heidi Faith, Founder, President and CEO of StillBirthDay, a highly specialized doula program. The two talk about the unique care roles a bereavement doula can play in the labor and delivery of stillborn babies.

Still Birthday: The Role of Bereavement Doulas in Childbirth


Host: Brian P. McDonough, MD, FAAFP  It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, specifically, and how can we leverage these understandings into better primary care? Dr. Brian McDonough is joined by Dr. Maureen Murphy, research scientist at the Wistar Institute at the University of Pennsylvania. Dr. Murphy has spent the past twenty years studying how genes affect breast cancer risk in women, particularly for African American populations. She discusses her findings on the discovery of p53 protein variants and how this advances the role for precision medicine in treating breast cancer.

Host: Brian P. McDonough, MD, FAAFP It's widely known that genetics, family history, race, and other factors all play important roles in cancer risk. But what kinds of roles do they play, specifically, and how can we leverage these understandings into better primary care? Dr. Brian McDonough is joined by Dr. Maureen Murphy, research scientist at the Wistar Institute at the University of Pennsylvania. Dr. Murphy has spent the past twenty years studying how genes affect breast cancer risk in women, particularly for African American populations. She discusses her findings on the discovery of p53 protein variants and how this advances the role for precision medicine in treating breast cancer.

Linking p53 Variation to Breast Cancer Risk in African American Women


FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy. Released May 18, 2017

FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy. Released May 18, 2017

FDA D.I.S.C.O.: Niraparib in Ovarian Cancer


Dorothy Mendenhall

Host: Maurice Pickard, MD   Guest: Peter Dawson, MD  In the male-dominated world of medicine, she dared to step forward and fight for fairness—graduating from Johns Hopkins Medical School with honors in the year 1900. But for physician Dorothy Reed Mendenhall, MD, the battle for equality was just beginning. In the name of improving the standards of care for women and infants, she faced the scorn of prejudiced doctors in an establishment marked by its unwillingness to change. Still, through the Gilded Age, two World Wars, and beyond, she kept up her fight—in the process, discovering new breakthroughs and saving lives, all while outperforming many of her male peers. Dorothy in a Man’s World is an inside look at the life and career of Dr. Mendenhall, documented by physician and pathologist Dr. Peter Dawson. This biographical tribute to one of medicine’s great female pioneers showcases the struggles women faced to make a name for themselves in the world of health care—in addition to the drastic improvements which have been made in the specific area of care for women and their infants. Dr. Dawson sits down with host Dr. Maurice Pickard as they explore Dr. Mendenhall's extraordinary life.

Host: Maurice Pickard, MD Guest: Peter Dawson, MD In the male-dominated world of medicine, she dared to step forward and fight for fairness—graduating from Johns Hopkins Medical School with honors in the year 1900. But for physician Dorothy Reed Mendenhall, MD, the battle for equality was just beginning. In the name of improving the standards of care for women and infants, she faced the scorn of prejudiced doctors in an establishment marked by its unwillingness to change. Still, through the Gilded Age, two World Wars, and beyond, she kept up her fight—in the process, discovering new breakthroughs and saving lives, all while outperforming many of her male peers. Dorothy in a Man’s World is an inside look at the life and career of Dr. Mendenhall, documented by physician and pathologist Dr. Peter Dawson. This biographical tribute to one of medicine’s great female pioneers showcases the struggles women faced to make a name for themselves in the world of health care—in addition to the drastic improvements which have been made in the specific area of care for women and their infants. Dr. Dawson sits down with host Dr. Maurice Pickard as they explore Dr. Mendenhall's extraordinary life.

Dorothy in a Man's World: An Inside Look at the Life and Career of Dr. Dorothy Mendenhall


Host: Matt Birnholz, MD   Guest: Ari Brooks, MD   Guest: Brian Englander, MD  Host Dr. Matt Birnholz is joined by Dr. Ari Brooks, Director of Endocrine and Oncology Surgery and Director of the Integrated Breast Center at Pennsylvania Hospital, and Dr. Brian Englander, Clinical Assistant Professor and Chair of the Department of Radiology at Pennsylvania Hospital. Drs. Brooks and Englander discuss the hot topics within breast cancer innovations. They touch upon the increase in involvement of genetics and genomic research that is impacting breast cancer treatment options, new breast imaging modalities, and continuity of care.

Host: Matt Birnholz, MD Guest: Ari Brooks, MD Guest: Brian Englander, MD Host Dr. Matt Birnholz is joined by Dr. Ari Brooks, Director of Endocrine and Oncology Surgery and Director of the Integrated Breast Center at Pennsylvania Hospital, and Dr. Brian Englander, Clinical Assistant Professor and Chair of the Department of Radiology at Pennsylvania Hospital. Drs. Brooks and Englander discuss the hot topics within breast cancer innovations. They touch upon the increase in involvement of genetics and genomic research that is impacting breast cancer treatment options, new breast imaging modalities, and continuity of care.

Hot Topics in Breast Cancer Innovations


There are real differences in men's and women's health concerns. The life expectancy gap is decreasing between men and women, but men still deal with higher rates of cardiovascular disease, prostate and testicular cancers, fluctuating testosterone levels, and fertility issues. Women’s health issues include cancer, reproductive and sexual health issues, osteoporosis prevention and management, nutrition and sports medicine. This series focuses on new developments in the diagnosis and treatment of gender-specific health issues.

Focus on Women's and Men’s Health

Host: Michael Krychman, MD  Feminine hygiene, though an important part of daily life, is rarely discussed openly,not even in clinical settings.  Host Dr. Michael Krychman sits down with Dr Alyssa Dweck, practicing gynecologist in New York and Assistant Clinical Professor at Mt. Sinai School of Medicine. They give essential tips for clinicians on how to talk to patients about feminine hygiene.

Host: Michael Krychman, MD Feminine hygiene, though an important part of daily life, is rarely discussed openly,not even in clinical settings. Host Dr. Michael Krychman sits down with Dr Alyssa Dweck, practicing gynecologist in New York and Assistant Clinical Professor at Mt. Sinai School of Medicine. They give essential tips for clinicians on how to talk to patients about feminine hygiene.

Keeping Up on Matters 'Down There:' Feminine Hygiene Advice for Clinicians


Host: Ana Maria Rosario   Guest: Anita L. Nelson, MD  Current clinical definitions and terminology for vaginal bleeding often fail to clarify frequency, duration, and volume. Moreover, standards of treatment sometimes differ between obstetric and gynecological points of view. Taken together, the risks for misclassifying and mistreating women with acute excessive vaginal bleeding are preventably high. Joining host Ana Maria Rosario at Omnia Education's Women's Health Annual Visit in Pasadena, CA to discuss key considerations for acute excessive vaginal bleeding is Dr. Anita Nelson, Professor Emeritus at the David Geffen School of Medicine at UCLA.

Host: Ana Maria Rosario Guest: Anita L. Nelson, MD Current clinical definitions and terminology for vaginal bleeding often fail to clarify frequency, duration, and volume. Moreover, standards of treatment sometimes differ between obstetric and gynecological points of view. Taken together, the risks for misclassifying and mistreating women with acute excessive vaginal bleeding are preventably high. Joining host Ana Maria Rosario at Omnia Education's Women's Health Annual Visit in Pasadena, CA to discuss key considerations for acute excessive vaginal bleeding is Dr. Anita Nelson, Professor Emeritus at the David Geffen School of Medicine at UCLA.

Obstetric vs Gynecological Priorities in Treating Acute Excessive Vaginal Bleeding


Host: Michael Krychman, MD  Women who experience low libido often feel embarrassed, lonely, and unsure where to turn or with whom to confide. Left unaddressed, this issue can have devastating effects on relationships.  Dr. Michael Krychman sits down with Amanda Parrish, nationally recognized patient advocate for women's sexual health, to talk about hypoactive sexual desire disorder (HSDD) and the need for clinicians to foster open conversations with patients about low libido. 

Host: Michael Krychman, MD Women who experience low libido often feel embarrassed, lonely, and unsure where to turn or with whom to confide. Left unaddressed, this issue can have devastating effects on relationships. Dr. Michael Krychman sits down with Amanda Parrish, nationally recognized patient advocate for women's sexual health, to talk about hypoactive sexual desire disorder (HSDD) and the need for clinicians to foster open conversations with patients about low libido.

Low Libido in Women: Ending the Conspiracy of Silence


Host: Patrice L Basanta-Henry, MD, MHSc, FACOG   Guest: LaToya Stephens, MD  Vaginal atrophy is a painful and emotionally distressing condition affecting many women, yet many suffer in silence. For those who find traditional treatment options to be ineffective, a vaginoplasty procedure already in use for cosmetic applications has been demonstrated to help counter the most severe symptoms. Join host Dr. Patrice Basanta Henry and Dr. Benita Stephens, Board Certified Ob-Gyn and founder of Ciao Bella Medical Center &amp; Spa in Atlanta, GA, as they discuss the benefits and risks of "vaginal rejuvenation" procedures for symptomatic vaginal atrophy.

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Guest: LaToya Stephens, MD Vaginal atrophy is a painful and emotionally distressing condition affecting many women, yet many suffer in silence. For those who find traditional treatment options to be ineffective, a vaginoplasty procedure already in use for cosmetic applications has been demonstrated to help counter the most severe symptoms. Join host Dr. Patrice Basanta Henry and Dr. Benita Stephens, Board Certified Ob-Gyn and founder of Ciao Bella Medical Center &amp; Spa in Atlanta, GA, as they discuss the benefits and risks of "vaginal rejuvenation" procedures for symptomatic vaginal atrophy.

Relief from Vaginal Atrophy: Restoring Sexuality through Vaginal Rejuvenation


Host: Alan S. Brown, MD, FACC, FAHA, FNLA   Guest: Robert Wild, MD, MPH, D.Phil.  Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to discuss types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception. The two discuss ways for clinicians to trace the source of dyslipidemia in these women, from primary to secondary causes, and how this knowledge can guide future contraception choices.  Dr. Robert Wild is Professor of OB/GYN and Adjunct Professor in Biostatistics and Epidemiology at the University of Oklahoma. He is also Adjunct Professor in Epidemiology at the University of Pittsburgh, and Adjunct Professor of Nutrition at Oklahoma State University. 

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Robert Wild, MD, MPH, D.Phil. Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to discuss types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception. The two discuss ways for clinicians to trace the source of dyslipidemia in these women, from primary to secondary causes, and how this knowledge can guide future contraception choices. Dr. Robert Wild is Professor of OB/GYN and Adjunct Professor in Biostatistics and Epidemiology at the University of Oklahoma. He is also Adjunct Professor in Epidemiology at the University of Pittsburgh, and Adjunct Professor of Nutrition at Oklahoma State University.

Selecting the Right Contraception for the Dyslipidemic Woman


Host: Jennifer Caudle, DO  Joining Dr. Jennifer Caudle to discuss top tips in breast cancer risk, screening, and detection is Dr. Monique Gary, breast surgical oncologist at Grand View Health in Sellersville, PA. Dr. Gary earned her medical degree from Philadelphia College of Osteopathic Medicine. She completed her internship and residency at University of Massachusetts Hospital and went on to complete her fellowship at Georgetown University Hospital.

Host: Jennifer Caudle, DO Joining Dr. Jennifer Caudle to discuss top tips in breast cancer risk, screening, and detection is Dr. Monique Gary, breast surgical oncologist at Grand View Health in Sellersville, PA. Dr. Gary earned her medical degree from Philadelphia College of Osteopathic Medicine. She completed her internship and residency at University of Massachusetts Hospital and went on to complete her fellowship at Georgetown University Hospital.

Breast Basics 101: What Every Woman Should Know About Breast Cancer Risk, Screening, & Detection


[Read the Article] The most common operation done worldwide is the cesarean or C-section. Cesarean delivery is lifesaving for obstructed labor and other obstetrical emergencies; however, as with any surgical procedure, there are risks of complications and overuse can be harmful to both mothers and newborns. There were about 22.9 million cesarean deliveries worldwide in 2012. Based on older analyses from the mid-1980s, the World Health Organization (WHO) recommends that cesarean delivery rates should not exceed 10 to 15 per 100 live births. In a study in the December 1 issue of JAMA, Harvard Researchers examine the relationship between cesarean delivery rates and maternal and infant death, and other adverse outcomes in children following planned cesarean delivery. The results indicate that the optimal cesarean delivery rate in relation to maternal and neonatal mortality is approximately 19 per 100 live births. Higher cesarean delivery rates were not associated with better outcomes in mothers and children. [Watch more videos of The JAMA Report]

<a href="http://jama.jamanetwork.com/article.aspx?articleid=2473490" rel="nofollow" target="_blank">[Read the Article]</a> The most common operation done worldwide is the cesarean or C-section. Cesarean delivery is lifesaving for obstructed labor and other obstetrical emergencies; however, as with any surgical procedure, there are risks of complications and overuse can be harmful to both mothers and newborns. There were about 22.9 million cesarean deliveries worldwide in 2012. Based on older analyses from the mid-1980s, the World Health Organization (WHO) recommends that cesarean delivery rates should not exceed 10 to 15 per 100 live births. In a study in the December 1 issue of JAMA, Harvard Researchers examine the relationship between cesarean delivery rates and maternal and infant death, and other adverse outcomes in children following planned cesarean delivery. The results indicate that the optimal cesarean delivery rate in relation to maternal and neonatal mortality is approximately 19 per 100 live births. Higher cesarean delivery rates were not associated with better outcomes in mothers and children. <a href="https://reachmd.com/programs/the-jama-report/" rel="nofollow" target="_blank">[Watch more videos of The JAMA Report]</a>

Cesarean Section Rates and Health Outcomes For Mothers and Babies


Host: Matt Birnholz, MD  Most women will readily testify that pelvic examinations are unpleasant experiences; they can be physically painful and induce anxiety. But recent studies have also indicated that examinations of asymptomatic, average-risk woman may lead to unexpectedly high rates false positives and unnecessary followup tests. So the perennial question resurfaces: are routine pelvic examinations more trouble than they're worth?  Join Dr. Matt Birnholz and guest Dr. Hannah Bloomfield, Chief of Research at the Minneapolis VA Medical Center, speaking at ACOG’s annual scientific meeting. They focus on the latest research behind this question of whether routine pelvic examinations are really necessary for monitoring patient health, and the potential pros and cons of abandoning this practice in annual OB/GYN checkups.

Host: Matt Birnholz, MD Most women will readily testify that pelvic examinations are unpleasant experiences; they can be physically painful and induce anxiety. But recent studies have also indicated that examinations of asymptomatic, average-risk woman may lead to unexpectedly high rates false positives and unnecessary followup tests. So the perennial question resurfaces: are routine pelvic examinations more trouble than they're worth? Join Dr. Matt Birnholz and guest Dr. Hannah Bloomfield, Chief of Research at the Minneapolis VA Medical Center, speaking at ACOG’s annual scientific meeting. They focus on the latest research behind this question of whether routine pelvic examinations are really necessary for monitoring patient health, and the potential pros and cons of abandoning this practice in annual OB/GYN checkups.

Should Annual Routine Pelvic Examinations Go the Way of the Dinosaurs?


Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG  Pregnancy loss can occur in any trimester of pregnancy and for several possible reasons. For clinicians who treat pregnant patients, delivering the bad news of pregnancy loss is an avoidable part of practice. How do health care professionals best counsel these patients and their loved ones through these difficult times? Host Dr. Renee Allen joins Dr. Jocelyn Slaughter-Moore, practicing OB/GYN at Heras Healthcare for Women and attending physician at Clearview Regional Medical Center in Monroe, GA, to discuss counseling and coping strategies for patients who have experienced pregnancy loss. 

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG Pregnancy loss can occur in any trimester of pregnancy and for several possible reasons. For clinicians who treat pregnant patients, delivering the bad news of pregnancy loss is an avoidable part of practice. How do health care professionals best counsel these patients and their loved ones through these difficult times? Host Dr. Renee Allen joins Dr. Jocelyn Slaughter-Moore, practicing OB/GYN at Heras Healthcare for Women and attending physician at Clearview Regional Medical Center in Monroe, GA, to discuss counseling and coping strategies for patients who have experienced pregnancy loss.

How to Counsel Patients Dealing with Pregnancy Loss


Host: Brian P. McDonough, MD, FAAFP   Guest: Charles N. Walker, MD  Dr. Charles Walker, Assistant Professor of Surgery in the Department of Urology at Yale University School of Medicine, shares clinical insights about penile prostheses, such as inflatable versus malleable devices, used as surgical gold standards to treat erectile dysfunction. 

Host: Brian P. McDonough, MD, FAAFP Guest: Charles N. Walker, MD Dr. Charles Walker, Assistant Professor of Surgery in the Department of Urology at Yale University School of Medicine, shares clinical insights about penile prostheses, such as inflatable versus malleable devices, used as surgical gold standards to treat erectile dysfunction.

Examining Penile Implants for Surgical Treatment of Erectile Dysfunction


Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG  In the US, more than one half of pregnant women are overweight or obese, and 8% of reproductive-aged women are extremely obese, putting them at a greater risk of pregnancy complications. In this episode, we review the magnitude of the problem, the anatomic and physiologic factors specific to the obese patient, and the maternal and fetal complications that can occur. Host Dr. Renee Allen welcomes Dr. Patrice Basanta Henry, an Ob-Gyn &amp; MFM at Atlanta Maternal Fetal Medicine, an affiliate of Mednax National Medical Group. Dr. Basanta-Henry’s clinical interests include intrauterine growth restriction and endocrine disorders in pregnancy.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG In the US, more than one half of pregnant women are overweight or obese, and 8% of reproductive-aged women are extremely obese, putting them at a greater risk of pregnancy complications. In this episode, we review the magnitude of the problem, the anatomic and physiologic factors specific to the obese patient, and the maternal and fetal complications that can occur. Host Dr. Renee Allen welcomes Dr. Patrice Basanta Henry, an Ob-Gyn &amp; MFM at Atlanta Maternal Fetal Medicine, an affiliate of Mednax National Medical Group. Dr. Basanta-Henry’s clinical interests include intrauterine growth restriction and endocrine disorders in pregnancy.

Obesity in the Pregnant Patient: Risks, Complications, and Management Strategies


Host: Shira Johnson, MD   Guest: Charles N. Walker, MD  Dr. Shira Johnson speaks with Dr. Charles Walker, Assistant Professor of Surgery in the Department of Urology at Yale University School of Medicine. The two focus on erectile dysfunction as a common complication for patients dealing with diabetes and heart disease, and ways that clinicians can help patients manage this problem through lifestyle modifications. Dr. Walker also introduces emerging pathophysiological understandings of ED as a potential predictor of diabetes.

Host: Shira Johnson, MD Guest: Charles N. Walker, MD Dr. Shira Johnson speaks with Dr. Charles Walker, Assistant Professor of Surgery in the Department of Urology at Yale University School of Medicine. The two focus on erectile dysfunction as a common complication for patients dealing with diabetes and heart disease, and ways that clinicians can help patients manage this problem through lifestyle modifications. Dr. Walker also introduces emerging pathophysiological understandings of ED as a potential predictor of diabetes.

Managing Erectile Dysfunction Stemming from Diabetes and Heart Disease


Host: Matt Birnholz, MD   Guest: Ronald J. Wapner, MD  Innovations in medical genetics are changing the practice of obstetrics and gynecology. With advancing knowledge of underlying genetic predispositions, doctors can provide more precisioned care plans for patients in women's health centers. Dr. Matt Birnholz talks with Dr. Ronald J Wapner, Professor of Obstetrics and Gynecology and Director of Reproductive Genetics at Columbia University, about how the ever-changing field of medical genetics is revolutionizing OB/GYN treatment options and patient care.

Host: Matt Birnholz, MD Guest: Ronald J. Wapner, MD Innovations in medical genetics are changing the practice of obstetrics and gynecology. With advancing knowledge of underlying genetic predispositions, doctors can provide more precisioned care plans for patients in women's health centers. Dr. Matt Birnholz talks with Dr. Ronald J Wapner, Professor of Obstetrics and Gynecology and Director of Reproductive Genetics at Columbia University, about how the ever-changing field of medical genetics is revolutionizing OB/GYN treatment options and patient care.

Bringing Medical Genetics into Obstetrics and Gynecology: The Future of Women's Health


Host: Jennifer Caudle, DO  There are many widely circulated myths regarding breast cancer, such as:  Beliefs that this disease affects women only. Fears that mammograms can cause cancers to spread. Assumptions that most patients with breast cancer have family histories positive for this disease.   Host Jennifer Caudle talks with guest Dr. Monique Gary, a fellowship-trained breast surgical oncologist at Grand View Health in Sellersville, Pennsylvania. Together, they dispel myths about breast cancer and talk about what patients can expect during a surgical oncologist appointment.

Host: Jennifer Caudle, DO There are many widely circulated myths regarding breast cancer, such as: <ul> <li>Beliefs that this disease affects women only.</li> <li>Fears that mammograms can cause cancers to spread.</li> <li>Assumptions that most patients with breast cancer have family histories positive for this disease. </li> </ul> Host Jennifer Caudle talks with guest Dr. Monique Gary, a fellowship-trained breast surgical oncologist at Grand View Health in Sellersville, Pennsylvania. Together, they dispel myths about breast cancer and talk about what patients can expect during a surgical oncologist appointment.

Breast Cancer's Reality Check: Separating Facts from Fiction for Patients


[Read the Article] An estimated 15 million Americans do some kind of rotating shift work, including overnights, evenings and early morning shifts. But can this type of shift work increase the risk of coronary heart disease? A new study examined the link between rotating night shift work and heart disease in a group of female nurses.Researchers at Brigham and Women's Hospital used data from the Nurses' Health Studies (1 and 2), which followed participants for a twenty-four year period. They specifically looked at 189,000 women who reported their lifetime exposure to rotating night shift work. Over the course of the study period, more than 10,000 new cases of coronary heart disease were reported.The results suggested that rotating night shift work was associated with modest risk of coronary heart disease, but further research is needed to help determine whether the association is related to specific work hours and/or individual characteristics.  [Watch more videos of The JAMA Report] 

<a href="http://jama.jamanetwork.com/article.aspx?articleid=2516715" rel="nofollow" target="_blank">[Read the Article]</a> An estimated 15 million Americans do some kind of rotating shift work, including overnights, evenings and early morning shifts. But can this type of shift work increase the risk of coronary heart disease? A new study examined the link between rotating night shift work and heart disease in a group of female nurses. Researchers at Brigham and Women's Hospital used data from the Nurses' Health Studies (1 and 2), which followed participants for a twenty-four year period. They specifically looked at 189,000 women who reported their lifetime exposure to rotating night shift work. Over the course of the study period, more than 10,000 new cases of coronary heart disease were reported. The results suggested that rotating night shift work was associated with modest risk of coronary heart disease, but further research is needed to help determine whether the association is related to specific work hours and/or individual characteristics. <a href="https://reachmd.com/programs/the-jama-report/" rel="nofollow" target="_blank">[Watch more videos of The JAMA Report]</a>

Does Working the Night Shift Increase the Risk of Heart Disease in Women?


Host: Barnett Mennen, MD   Guest: Angela DeMichele, MD, MSCE  Penn Medicine’s Breast Cancer Translational Center of Excellence (TCE), known as the 2-PREVENT TCE is led by Drs. Lewis Chodosh and Angela DeMichele. 2-PREVENT TCE aims to address one of the greatest challenges in breast cancer treatment: the high rate of relapse and late treatment effects among breast cancer survivors. Host Dr. Barry Mennen welcomes Dr. Angela DeMichele, the Alan and Jill Miller Endowed Chair in Breast Cancer Excellence, Professor of Medicine and Epidemiology, and Co-Leader of the Breast Cancer Research Program at the Abramson Cancer Center of the University of Pennsylvania School Of Medicine.

Host: Barnett Mennen, MD Guest: Angela DeMichele, MD, MSCE Penn Medicine’s Breast Cancer Translational Center of Excellence (TCE), known as the 2-PREVENT TCE is led by Drs. Lewis Chodosh and Angela DeMichele. 2-PREVENT TCE aims to address one of the greatest challenges in breast cancer treatment: the high rate of relapse and late treatment effects among breast cancer survivors. Host Dr. Barry Mennen welcomes Dr. Angela DeMichele, the Alan and Jill Miller Endowed Chair in Breast Cancer Excellence, Professor of Medicine and Epidemiology, and Co-Leader of the Breast Cancer Research Program at the Abramson Cancer Center of the University of Pennsylvania School Of Medicine.

Addressing Breast Cancer's High Recurrence Rates: The Breast Cancer Translational Center of Excellence (TCE)


Host: Michael Krychman, MD  The primary purpose of contraception is to separate sex from procreation. However, sexual function is rarely addressed or considered in the context of making contraceptive choices. Dr. Michael Krychman speaks with Dr. Rachel Perry, Assistant Professor of OB/GYN at the University of California-Irvine, about the various complex sexual health impacts of oral contraceptives, IUDs, condoms, and permanent sterilization procedures.

Host: Michael Krychman, MD The primary purpose of contraception is to separate sex from procreation. However, sexual function is rarely addressed or considered in the context of making contraceptive choices. Dr. Michael Krychman speaks with Dr. Rachel Perry, Assistant Professor of OB/GYN at the University of California-Irvine, about the various complex sexual health impacts of oral contraceptives, IUDs, condoms, and permanent sterilization procedures.

Selecting the Best Contraceptive Methods: A Sexual Health Perspective


Host: Michael Krychman, MD  Ovarian cancer is among the most highly prevalent and deadly cancers in existence, and in the struggle to care for patients and protect their quality of life, clinical standards in diagnostic screening and treatment protocols must change frequently.   Joining host Dr. Michael Krychman to discuss advances in treatment and prevention of ovarian cancer, with special focus on sexual health priorities, is guest Dr. Leslie Randall. Dr. Randall is Associate Professor of Obstetrics and Gynecology at the University of California-Irvine, and also Director of UC’s gynecologic oncology fellowship program.

Host: Michael Krychman, MD Ovarian cancer is among the most highly prevalent and deadly cancers in existence, and in the struggle to care for patients and protect their quality of life, clinical standards in diagnostic screening and treatment protocols must change frequently. Joining host Dr. Michael Krychman to discuss advances in treatment and prevention of ovarian cancer, with special focus on sexual health priorities, is guest Dr. Leslie Randall. Dr. Randall is Associate Professor of Obstetrics and Gynecology at the University of California-Irvine, and also Director of UC’s gynecologic oncology fellowship program.

Life After Ovarian Cancer: Protecting Sexual and General Health for Survivors


The best podcasts about ourselves as well as the world through the lense of Science. Specific topics include things about our brain, emotions to biology, physics and more!

Best Episodes on Science, Humans & The World

The best self improvement podcast episodes. From improving productivity, to finding purpose in your life to what constitutes freedom, this topic is on anything and everything that can help people to improve their lives. Add episodes you're interested into your queue below!